Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
The Hormuz blockade impacts food supplies; the EU approves a €25 million fuel subsidy for Spanish fisheries.

The Hormuz blockade impacts food supplies; the EU approves a €25 million fuel subsidy for Spanish fisheries.

汇通财经汇通财经2026/06/04 13:18
Show original
  1. The European Commission on Thursday approved a €25 million aid plan from the Spanish government to support fishing fleets affected by soaring fuel costs due to the Middle East war and the closure of the Strait of Hormuz.
  2. The aid will be granted in the form of direct subsidies: for diesel purchased by companies between March 22, 2026 and June 30, 2026, a subsidy of €0.20 per litre can be obtained, with a maximum of €200,000 per vessel and a maximum of €400,000 per vessel owner.
  3. This aid can cover up to 70% of the additional fuel costs caused by the Middle East crisis. Brussels believes the plan is “necessary, appropriate, and proportionate,” aiming to promote the development of economic activities without negatively affecting trading conditions.
  4. The European Commission stated that the plan is based on a “clearly estimated budget” and will temporarily support the development of companies engaged in primary fisheries production.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage